Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.139NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.139NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.508NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.508NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.508NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.94NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.94NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.94NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.463NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.463NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.463NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.357NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.357NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.357NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.318NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.318NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.318NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.557NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.557NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.557NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.119NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.119NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.119NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.160NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.160NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.160NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
D.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
D.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
D.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.447NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.447NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.447NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.110.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.110.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.110.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.180NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.180NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.180NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.155NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.155NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.155NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.92NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.92NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.92NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.145NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.145NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.145NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.120NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.120NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.120NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used